-
Chinese medicine stock R & D expense ranking list is released! Tasly, Red Sun, Katazai 9 more than
Time of Update: 2022-09-20
A few days ago, the performance disclosure of listed companies in the first half of 2022 came to an end, 449 pharmaceutical companies have handed over report cards, and the research and development e
-
Science | Song Yuanbin/Shan Liang et al. Develop a new humanized mouse model of human red blood cell growth and maturation
Time of Update: 2021-03-23
In recent years, Stephanie Halene, as the corresponding author, has published many research papers in internationally renowned journals such as Science, Immunity, Blood, and Nature Communications.
-
Domestic paint production growth slowed paint business performance is still red
Time of Update: 2021-01-21
China Coatings Network News: Under the background of the domestic economy entering the "normalization" development, the real estate industry investment growth rate continued to decline, to coatings and titanium dioxide industry development has caused a great impact, it is understood that in the first half of 2015, due to market demand, the total amount of paint in April and May fell in a single month, January to May paint production growth also fell to 5%.
-
"Pharmaceutical leader" market leading policy of basic drugs, red bag Novo Nordisk Q3, China market growth 17%
Time of Update: 2019-11-06
Policy review of the pilot cities of the top 10 clinics; Zhengda Tianqing's fourth generation EGFR-TKI enters the clinical practice to overcome the drug resistance problem of oxitinib; Fosun Pharmaceutical's "spin off" action in further gland Pharma plans to be listed in India Great!